zane house
macro research, systems engineering
I build and deploy systems that filter markets through macro.
There's no shortage of information anymore. There's a shortage of signal. Most of what moves through markets is noise, and most people can't tell which is which. At Elysium, I build cause-and-effect frameworks that cut through it, reading regime shifts and rate cycles through incentives and historical precedent to isolate the few forces that actually move price. Those frameworks become the systems I deploy: repeatable, testable, and built to hold up when the regime turns.
Explore Elysium →
My Skillsets
Macro Research
Reading the macro regime through rate cycles, policy, and the Fed's balance sheet, which sets my filter for the names I weight and the ones I rule out entirely.
Quantitative Research
Reading positioning through the options chain, from dealer exposure to expirations and where price is pinned. Structural data I use to time entries, not to build the thesis.
Systems Engineering
I build and ship the systems that run the frameworks, taking each one from raw research to a working tool, end to end.
Selected Research
Independent equity and macro research. Full thesis papers, sourced and dated.
Micron Technology
Bullish on the HBM and data center re-rating. Called the AI-driven memory cycle in December; the stock has since 4x'd past every analyst target.
Read the paper →Eli Lilly
Bullish over 12 to 24 months on GLP-1 leadership, with the first unrestricted oral GLP-1 as the near-term catalyst and litigation as the main risk. Paired with the Novo Nordisk note as a relative-value view on the GLP-1 share shift.
Read the paper →Novo Nordisk
Bearish on share loss to Lilly, a growing legal overhang, and a breakdown in technical structure. The short side of the GLP-1 pair, with a falsifiable call and defined downside targets.
Read the paper →Contact
For research access, collaboration, or inquiries.